beclomethasone dipropionate hydrofluoroalkane Recently Published Documents

Pharmacokinetic Profile of Beclomethasone Dipropionate Hydrofluoroalkane After Intranasal Administration Versus Oral Inhalation in Healthy Subjects: Results of a Single-Dose, Randomized, Open-Label, 3-Period Crossover Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.04.023 ◽

2012 ◽

Vol 34 (6) ◽

pp. 1422-1431 ◽

Cited By ~ 10

Author(s):

Paul H. Ratner ◽

Amy Melchior ◽

Stephanie A. Dunbar ◽

Sudeesh K. Tantry ◽

Paul M. Dorinsky

Keyword(s):

Single Dose ◽

Crossover Study ◽

Healthy Subjects ◽

Intranasal Administration ◽

Pharmacokinetic Profile ◽

Open Label ◽

Oral Inhalation ◽

Effective Nasal Symptom Relief and Improvement in Health-Related Quality of Life in Subjects with Perennial Allergic Rhinitis Following 6-Week Once-Daily Treatment with Beclomethasone Dipropionate Hydrofluoroalkane Nasal Aerosol

10.1016/j.jaci.2011.12.266 ◽

2012 ◽

Vol 129 (2) ◽

pp. AB188

Author(s):

W. Carr ◽

E.O. Meltzer ◽

A. Finn ◽

P.M. Dorinsky ◽

L. Kelley ◽

...

Keyword(s):

Symptom Relief ◽

Nasal Symptom ◽

Health Related Quality ◽

Once Daily ◽

Related Quality ◽

Health Related ◽

Once-Daily Treatment With Beclomethasone Dipropionate Hydrofluoroalkane Nasal Aerosol (320 mcg/d) Provides Substantial Nasal Symptom Relief in Subjects With Perennial Allergic Rhinitis

10.1016/j.jaci.2011.12.270 ◽

2012 ◽

Vol 129 (2) ◽

pp. AB189

Author(s):

B.M. Prenner ◽

S. Weinstein ◽

W. Pleskow ◽

A. Tankelevich ◽

Y. Ding ◽

...

Keyword(s):

Allergic Rhinitis ◽

Symptom Relief ◽

Nasal Symptom ◽

Daily Treatment ◽

Once Daily ◽

Once-Daily Treatment With Beclomethasone Dipropionate Hydrofluoroalkane Nasal Aerosol (320 mcg/d) Is Not Associated With Hypothalamic-Pituitary-Adrenal Axis Suppression in Adolescent Subjects With Perennial Allergic Rhinitis

10.1016/j.jaci.2011.12.267 ◽

2012 ◽

Vol 129 (2) ◽

pp. AB188

Author(s):

F.C. Hampel ◽

P.H. Ratner ◽

S.D. Miller ◽

A. Melchior ◽

S.A. Dunbar ◽

...

Keyword(s):

Allergic Rhinitis ◽

Hypothalamic Pituitary Adrenal Axis ◽

Daily Treatment ◽

Once Daily ◽

Hypothalamic Pituitary Adrenal ◽

Adrenal Axis ◽

Beclomethasone Dipropionate Hydrofluoroalkane ◽

Pituitary Adrenal Axis

Once Daily Treatment with Beclomethasone Dipropionate Hydrofluoroalkane Nasal Aerosol Is Safe and Effective in Children (6-11 Years of Age) With Seasonal Allergic Rhinitis

10.1016/j.jaci.2011.12.268 ◽

2012 ◽

Vol 129 (2) ◽

pp. AB188 ◽

Cited By ~ 1

Author(s):

N. Segall ◽

L. Mansfield ◽

N. Amar ◽

P.M. Dorinsky ◽

L. Kelley ◽

...

Keyword(s):

Allergic Rhinitis ◽

Seasonal Allergic Rhinitis ◽

Daily Treatment ◽

Once Daily ◽

Long-Term (52-Week) Treatment With Beclomethasone Dipropionate Hydrofluoroalkane Nasal Aerosol (320 mcg Once Daily) Is Safe and Effective in Adult and Adolescent Subjects With Perennial Allergic Rhinitis

10.1016/j.jaci.2011.12.269 ◽

2012 ◽

Vol 129 (2) ◽

pp. AB189 ◽

Cited By ~ 3

Author(s):

A.S. Nayak ◽

C.P. Andrews ◽

D.I. Bernstein ◽

P.M. Dorinsky ◽

A. Tankelevich ◽

...

Keyword(s):

Allergic Rhinitis ◽

Once Daily ◽

Incidence of Exacerbations and Hospitalizations Is Reduced and Time to Exacerbations Is Prolonged with Mometasone Furoate Dry Powder Inhaler Versus Beclomethasone Dipropionate Hydrofluoroalkane Aerosol in Patients with Mild Asthma

Health Outcomes Research in Medicine ◽

10.1016/j.ehrm.2010.08.001 ◽

2010 ◽

Vol 1 (2) ◽

pp. e93-e102 ◽

Cited By ~ 1

Author(s):

Prakash Navaratnam ◽

Eduardo Urdaneta ◽

John McLaughlin ◽

Howard S. Friedman

Keyword(s):

Dry Powder Inhaler ◽

Mometasone Furoate ◽

Mild Asthma ◽

Dry Powder ◽

COMPARATIVE EFFECTIVENESS OF MOMETASONE FUROATE INHALATION POWDER VERSUS BECLOMETHASONE DIPROPIONATE HYDROFLUOROALKANE AEROSOL IN THE TREATMENT OF CONTROLLER-NAIVE PATIENTS WITH MILD, PERSISTENT ASTHMA

CHEST Journal ◽

10.1378/chest.136.4_meetingabstracts.8s-a ◽

2009 ◽

Vol 136 (4) ◽

pp. 8S

Author(s):

Prakash Navaratnam ◽

Eduardo R. Urdaneta ◽

John McLaughlin ◽

Howard S. Friedman

Keyword(s):

Comparative Effectiveness ◽

Persistent Asthma ◽

Mometasone Furoate ◽

Beclomethasone Dipropionate Hydrofluoroalkane ◽

Mild Persistent Asthma ◽

Inhalation Powder

Outcomes and costs of patients with persistent asthma treated with beclomethasone dipropionate hydrofluoroalkane or fluticasone propionate

Advances in Therapy ◽

10.1007/s12325-009-0056-z ◽

2009 ◽

Vol 26 (8) ◽

pp. 762-775 ◽

Cited By ~ 4

Author(s):

Maureen J. Lage ◽

Gary N. Gross ◽

Corrine Brewster ◽

Anthony Spalitto

Keyword(s):

Fluticasone Propionate ◽

Persistent Asthma ◽